Bulletin
Investor Alert

Gilead Sciences Inc.

NAS: GILD

GO
/marketstate/country/us

After Hours

 --Real time quotes

May 24, 2022, 6:27 p.m.

/zigman2/quotes/210293917/composite

$

64.60

Change

+0.25 +0.39%

Volume

Volume 1.54m

Real time quotes

/zigman2/quotes/210293917/composite

Today's close

$ 63.66

$ 64.35

Change

+0.69 +1.08%

Day low

Day high

$63.43

$64.41

Open

52 week low

52 week high

$57.19

$74.12

Open

Insider Actions for Gilead Sciences Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
05/05/2022 Kevin E. Lofton
Director
2,444   Award at $0 per share. 0
05/05/2022 Jacqueline K. Barton
Director
2,444   Award at $0 per share. 0
05/05/2022 Harish M. Manwani
Director
2,444   Award at $0 per share. 0
05/05/2022 Javier J. Rodriguez
Director
2,444   Award at $0 per share. 0
05/05/2022 Anthony Welters
Director
2,444   Award at $0 per share. 0
05/05/2022 Jeffrey A. Bluestone
Director
2,444   Award at $0 per share. 0
05/05/2022 Harish M. Manwani
Director
477   Derivative/Non-derivative trans. at $61.35 per share. 29,263
05/03/2022 Kevin E. Lofton
Director
2,223   Derivative/Non-derivative trans. at $0 per share. 0
05/03/2022 Jacqueline K. Barton
Director
2,223   Derivative/Non-derivative trans. at $0 per share. 0
05/03/2022 Harish M. Manwani
Director
2,223   Derivative/Non-derivative trans. at $0 per share. 0
05/03/2022 Javier J. Rodriguez
Director
2,223   Derivative/Non-derivative trans. at $0 per share. 0
05/03/2022 Anthony Welters
Director
2,223   Derivative/Non-derivative trans. at $0 per share. 0
05/03/2022 Jeffrey A. Bluestone
Director
2,223   Derivative/Non-derivative trans. at $0 per share. 0
05/03/2022 Sandra J. Horning
Director
1,112   Derivative/Non-derivative trans. at $0 per share. 0
05/03/2022 Harish M. Manwani
Director
349   Derivative/Non-derivative trans. at $60.33 per share. 21,055
04/28/2022 Kevin E. Lofton
Director
16,322   Derivative/Non-derivative trans. at $25.62 per share. 418,169
03/11/2022 Brett A. Pletcher
EVP,Corp Affairs & Gen Counsel
3,634   Disposition at $58.24 per share. 211,644
03/10/2022 Daniel P. O'Day
Chairman & CEO; Director
11,052   Derivative/Non-derivative trans. at $57.92 per share. 640,131
03/10/2022 Andrew D. Dickinson
Chief Financial Officer
3,602   Derivative/Non-derivative trans. at $57.92 per share. 208,627
03/10/2022 Merdad V. Parsey
Chief Medical Officer
3,505   Derivative/Non-derivative trans. at $57.92 per share. 203,009
03/10/2022 Johanna Mercier
Chief Commercial Officer
3,221   Derivative/Non-derivative trans. at $57.92 per share. 186,560
03/10/2022 Brett A. Pletcher
EVP,Corp Affairs & Gen Counsel
2,089   Derivative/Non-derivative trans. at $57.92 per share. 120,994
03/10/2022 Diane E. Wilfong
SVP, Controller & CAO
935   Derivative/Non-derivative trans. at $57.92 per share. 54,155
03/10/2022 Daniel P. O'Day
Chairman & CEO; Director
13,203   Derivative/Non-derivative trans. at $0 per share. 0
03/10/2022 Daniel P. O'Day
Chairman & CEO; Director
10,800   Derivative/Non-derivative trans. at $0 per share. 0
03/10/2022 Andrew D. Dickinson
Chief Financial Officer
4,108   Derivative/Non-derivative trans. at $0 per share. 0
03/10/2022 Andrew D. Dickinson
Chief Financial Officer
3,025   Derivative/Non-derivative trans. at $0 per share. 0
03/10/2022 Andrew D. Dickinson
Chief Financial Officer
768   Derivative/Non-derivative trans. at $0 per share. 0
03/10/2022 Merdad V. Parsey
Chief Medical Officer
4,157   Derivative/Non-derivative trans. at $0 per share. 0
03/10/2022 Merdad V. Parsey
Chief Medical Officer
3,455   Derivative/Non-derivative trans. at $0 per share. 0
03/10/2022 Johanna Mercier
Chief Commercial Officer
3,962   Derivative/Non-derivative trans. at $0 per share. 0
03/10/2022 Johanna Mercier
Chief Commercial Officer
3,025   Derivative/Non-derivative trans. at $0 per share. 0
03/10/2022 Brett A. Pletcher
EVP,Corp Affairs & Gen Counsel
3,130   Derivative/Non-derivative trans. at $0 per share. 0
03/10/2022 Brett A. Pletcher
EVP,Corp Affairs & Gen Counsel
2,593   Derivative/Non-derivative trans. at $0 per share. 0
03/10/2022 Diane E. Wilfong
SVP, Controller & CAO
1,272   Derivative/Non-derivative trans. at $0 per share. 0
03/10/2022 Diane E. Wilfong
SVP, Controller & CAO
2,025   Derivative/Non-derivative trans. at $0 per share. 0
03/01/2022 Daniel P. O'Day
Chairman & CEO; Director
23,245   Derivative/Non-derivative trans. at $60.26 per share. 1,400,743
03/01/2022 Daniel P. O'Day
Chairman & CEO; Director
42,922   Derivative/Non-derivative trans. at $0 per share. 0
03/01/2022 Daniel P. O'Day
Chairman & CEO; Director
11,362   Derivative/Non-derivative trans. at $0 per share. 0
02/15/2022 Andrew D. Dickinson
Chief Financial Officer
348   Award at $52.13 per share. 18,141
02/15/2022 Merdad V. Parsey
Chief Medical Officer
348   Award at $52.13 per share. 18,141
02/15/2022 Brett A. Pletcher
EVP,Corp Affairs & Gen Counsel
348   Award at $52.13 per share. 18,141
02/09/2022 Brett A. Pletcher
EVP,Corp Affairs & Gen Counsel
1,691   Disposition at $63.89 per share. 108,037
02/06/2022 Andrew D. Dickinson
Chief Financial Officer
767   Derivative/Non-derivative trans. at $63.9 per share. 49,011
02/06/2022 Brett A. Pletcher
EVP,Corp Affairs & Gen Counsel
1,036   Derivative/Non-derivative trans. at $63.9 per share. 66,200
02/06/2022 Diane E. Wilfong
SVP, Controller & CAO
520   Derivative/Non-derivative trans. at $63.9 per share. 33,228
02/06/2022 Andrew D. Dickinson
Chief Financial Officer
1,817   Derivative/Non-derivative trans. at $0 per share. 0
02/06/2022 Brett A. Pletcher
EVP,Corp Affairs & Gen Counsel
2,727   Derivative/Non-derivative trans. at $0 per share. 0
02/06/2022 Diane E. Wilfong
SVP, Controller & CAO
1,864   Derivative/Non-derivative trans. at $0 per share. 0
02/01/2022 Brett A. Pletcher
EVP,Corp Affairs & Gen Counsel
14,061   Disposition at $68.54 per share. 963,740

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
29 Purchases
10 Sales
155,243
52,109
Last 6 months
46 Purchases
19 Sales
419,393
113,708
Last 12 months
58 Purchases
25 Sales
456,887
136,445

Officers and Executives

Mr. Daniel P. O'Day
Chairman & Chief Executive Officer
Mr. Andrew D. Dickinson
Chief Financial Officer
Dr. Merdad V. Parsey
Chief Medical Officer
Dr. Flavius Martin
Executive Vice President-Research
Ms. Johanna Mercier
Chief Commercial Officer
Dr. Tomas Cihlar
Vice President-Virology
Dr. Linda Slanec Higgins
Senior VP-Research & External Innovation
Dr. Mark Genovese
Senior Vice President-Inflammation Development
Ms. Janet Dorling
SVP-Global Commercial Product Strategy
Ms. Monica Tellado
Senior Vice President-Finance
Dr. William Grossman
Senior VP-Oncology Clinical Development
Dr. Adam Levy
Executive Director-Investor Relations
Mr. Brett A. Pletcher
Secretary, Chief Compliance Officer & Executive VP
Dr. Taiyin Yang
EVP-Pharmaceutical Development & Manufacturing
Ms. Diane E. Wilfong
Chief Accounting Officer & Senior Vice President
Ms. Jacquie Ross
Investor Relations Contact
Ms. Jyoti K. Mehra
Executive Vice President-Human Resources
Dr. Sandra J. Horning
Independent Director
Mr. Javier J. Rodriguez
Independent Director
Mr. Anthony Welters
Independent Director
Dr. Jeffrey A. Bluestone
Independent Director
Mr. Kevin E. Lofton
Lead Independent Director
Ms. Kelly A. Kramer
Independent Director
Dr. Jacqueline K. Barton
Independent Director
Mr. Harish M. Manwani
Independent Director
Link to MarketWatch's Slice.